Nanobody-based bioPROTAC for viral protein degradation provides an antiviral strategy for porcine arterivirus.

J Nanobiotechnology · 2026 · PMC13200423 · PMID 41935279

Europe PMC DOI

hedged sentence

0.0585

closest p · 1.2× alpha

0.0585

boldest claim

The sentences

did not reach statistical significanceP = 0.0585so close (0.05 < p ≤ 0.1)

However, this difference did not reach statistical significance compared with the Mock group (χ2=3.543; df = 1; P = 0.0585).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.